Full-Time
Posted on 6/22/2025
Healthcare solutions for improved patient outcomes
No salary listed
Junior, Mid
Bengaluru, Karnataka, India
Solventum focuses on enhancing healthcare by providing solutions that aim to improve patient outcomes and safety. Their products are designed to streamline healthcare processes, making them more efficient and effective. Unlike many competitors, Solventum emphasizes a continuous problem-solving approach, ensuring that they adapt and respond to the evolving needs of healthcare providers and patients. The primary goal of Solventum is to create a healthcare environment that is not only smarter but also safer, ultimately leading to better quality of life for individuals.
Company Size
5,001-10,000
Company Stage
N/A
Total Funding
N/A
Headquarters
N/A
Founded
N/A
Help us improve and share your feedback! Did you find this helpful?
Health Insurance
Dental Insurance
Vision Insurance
Life Insurance
Disability Insurance
Health Savings Account/Flexible Spending Account
Remote Work Options
Paid Vacation
Paid Sick Leave
Paid Holidays
Hybrid Work Options
Relocation Assistance
The Attest™ Super Rapid VH2O2 Clear Challenge Pack integrates biological and chemical performance indicators in a ready-to-use design to support every load monitoring1U.S. hospital infections affect 1 in 31 patients;2 new all-in-one solution is aimed at making expert-recommended safety practices in steam sterilization3 feasible for VH2O2 low-temperature methodTest pack is U.S. FDA-cleared for routine monitoring across multiple sterilizer brands, models and cycle types, and is designed to streamline workflow and simplify inventory management for sterile processing teamsST PAUL, Minn., June 9, 2025 /PRNewswire/ -- Solventum, a global MedTech leader at the forefront of infection prevention innovation, today announced the launch of its Attest™ Super Rapid Vaporized Hydrogen Peroxide (VH2O2) Clear Challenge Pack. The ready-to-use test integrates two previously FDA-cleared indicators – a biological indicator (BI) for confirming microbial neutralization and a chemical indicator (CI) for verifying proper sterilizer function – into a single-use test pack with a transparent container.Attest™ Super Rapid VH2O2 Clear Challenge PackMedical instrument sterility is a critical component in the fight against hospital-associated infections, which impact one in every 31 hospital patients in the U.S.4 The practice of every load monitoring – using dual indicators (both BIs and CIs) to verify the efficacy of every sterilization cycle for each batch of instruments – is recommended by industry guidelines and expert consensus to help minimize patient safety risks.This unique combination makes the Attest™ Super Rapid VH2O2 Clear Challenge Pack the first and only preassembled VH2O2 test pack that is U.S. FDA-cleared for routine monitoring across multiple sterilizer brands, models and cycle types*, offering:Convenience: preassembled, ready-to-use pack eliminates the step of assembling testing pouches with separate indicators, saving time and mitigating the risk of errors inherent to manual preparation, like incorrect indicator placement or omission of an indicator.preassembled, ready-to-use pack eliminates the step of assembling testing pouches with separate indicators, saving time and mitigating the risk of errors inherent to manual preparation, like incorrect indicator placement or omission of an indicator. Accuracy: engineered to more accurately simulate the environment within a wrapped set of surgical instruments during a VH2O2 cycle
ST. PAUL, Minn., April 17, 2025 /PRNewswire/ -- Solventum (NYSE: SOLV) will release its first quarter fiscal 2025 financial results on Thursday, May 8, 2025, after the U.S. financial markets close. After the release, Solventum management will host a webcast to discuss the results and its business. Other forward-looking and material information may also be discussed during the webcast
In this first-of-its-kind partnership for its Dental Solutions business, Solventum, formerly 3M Health Care, is striving to focus on longevity and durability of permanent same-day restorative dental offerings, reaffirming its commitment to solving industry's toughest problemsPartnership aims to integrate innovative new material science and disruptive technology like chairside 3D printing to optimize workflows, enhance procedural efficiency and benefit both patients and practitioners ST. PAUL, Minn., March 25, 2025 /PRNewswire/ -- Solventum (NYSE: SOLV), the leader in dental composites and restorative dentistry, today announced a strategic partnership with SprintRay, a leading provider of chairside 3D dental printing, to meet the needs of dentists with in-office chairside 3D printed crowns, inlays, onlays and more. This research and development (RD) and commercialization agreement is focused on developing and bringing to market high-quality, durable and permanent same-day restorations – with the quality patients and dentists expect from the current multi-visit laboratory fabricated procedures
ST. PAUL, Minn., March 12, 2025 /PRNewswire/ -- Solventum (NYSE: SOLV), formerly 3M Health Care, today announced the launch of the Attest™ eBowie-Dick Test System (eBowie-Dick System), an electronic test card and auto-reader for sterilization testing that eliminates the need for visual interpretation of results and manual documentation